Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLEEVEC for Gastrointestinal stromal tumour: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 28 adverse event reports in the FDA FAERS database where GLEEVEC was used for Gastrointestinal stromal tumour.

Most Reported Side Effects for GLEEVEC

Side Effect Reports % Deaths Hosp.
Death 72 27.1% 72 3
Nausea 26 9.8% 3 10
Diarrhoea 24 9.0% 2 9
Fatigue 23 8.7% 1 8
Vomiting 23 8.7% 3 11
Fall 20 7.5% 1 12
Muscle spasms 18 6.8% 1 8
Asthenia 15 5.6% 1 10
Malaise 15 5.6% 2 8
Rash 14 5.3% 0 3
Malignant neoplasm progression 12 4.5% 4 8
Swelling 12 4.5% 1 7
Myalgia 11 4.1% 0 3
Pain 11 4.1% 0 6
Cerebrovascular accident 10 3.8% 2 4

Other Indications for GLEEVEC

Chronic myeloid leukaemia (94) Gastric cancer (9) Neoplasm malignant (9) Soft tissue cancer (7) Soft tissue neoplasm (7) Soft tissue sarcoma (6) Acute lymphocytic leukaemia (5)

Other Drugs Used for Gastrointestinal stromal tumour

IMATINIB (5,587) RIPRETINIB (3,351) AVAPRITINIB (3,345) SUNITINIB MALATE (1,696) REGORAFENIB (473) SUNITINIB (297) GLIVEC (231) CABOZANTINIB S-MALATE (106) NILOTINIB (104) SUTENT (83)

Related Pages

GLEEVEC Full Profile All Gastrointestinal stromal tumour Drugs GLEEVEC Demographics GLEEVEC Timeline